G Fürstenberger
Comparison of seminal vesicle, non-malignant and malignant prostate tissues with gene expression patterns using quantitative real-time PCR
Morant R, Vuaroqueaux V, Diener P, Fürstenberger G, Horica C, Németh T, Sulmoni M, Eppenberger U, Eppenberger-Castori S. Comparison of seminal vesicle, non-malignant and malignant prostate tissues with gene expression patterns using quantitative real-time PCR. Int J Clin Pharmacol Ther 2011; 49:86-7.
01.01.2011Comparison of seminal vesicle, non-malignant and malignant prostate tissues with gene expression patterns using quantitative real-time PCR
01.01.2011Int J Clin Pharmacol Ther 2011; 49:86-7
Morant R, Vuaroqueaux V, Diener Pierre-André, Fürstenberger G, Horica C, Németh T, Sulmoni M, Eppenberger U, Eppenberger-Castori S
Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
Boneberg E, Senn H, Otto F, Dupont-Lampert V, Beer G, Füzesi L, Steininger H, Öhlschlegel C, Hoefer M, Legler D, Fürstenberger G. Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer. Br J Cancer 2009; 101:605-14.
18.08.2009Angiogenesis and lymphangiogenesis are downregulated in primary breast cancer
18.08.2009Br J Cancer 2009; 101:605-14
Boneberg E-M, Senn H-J, Otto F, Dupont-Lampert V, Beer G M, Füzesi L, Steininger H, Öhlschlegel Christian, Hoefer M M, Legler D F, Fürstenberger G
Die Primärbehandlung des frühen Mammakarzinoms
Kapp U, Fürstenberger G, Thürlimann B. Die Primärbehandlung des frühen Mammakarzinoms - Internationale St. Gallen-Konsensus Konferenz 2007. Schweizer Zeitschrift für Onkologie 2007; 4:6-10.
01.01.2007Die Primärbehandlung des frühen Mammakarzinoms
01.01.2007Schweizer Zeitschrift für Onkologie 2007; 4:6-10
Kapp U, Fürstenberger G, Thürlimann Beat
Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer
Fürstenberger G, von Moos R, Lucas R, Thürlimann B, Senn H, Hamacher J, Boneberg E. Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer. BJC 2006; 94:524-31.
27.02.2006Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer
27.02.2006BJC 2006; 94:524-31
Fürstenberger G, von Moos R, Lucas R, Thürlimann Beat, Senn H-J, Hamacher J, Boneberg E-M
Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
Dannull J, Diener P, Prikler L, Fürstenberger G, Cerny T, Schmid U, Ackermann D, Groettrup M. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer. Cancer research 2000; 60:5522-8.
01.10.2000Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer
01.10.2000Cancer research 2000; 60:5522-8
Dannull J, Diener P A, Prikler L, Fürstenberger G, Cerny Thomas, Schmid U, Ackermann D K, Groettrup M